JP5132071B2 - 皮膚外用剤 - Google Patents
皮膚外用剤 Download PDFInfo
- Publication number
- JP5132071B2 JP5132071B2 JP2006097154A JP2006097154A JP5132071B2 JP 5132071 B2 JP5132071 B2 JP 5132071B2 JP 2006097154 A JP2006097154 A JP 2006097154A JP 2006097154 A JP2006097154 A JP 2006097154A JP 5132071 B2 JP5132071 B2 JP 5132071B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- external preparation
- capsaicin
- weight
- pruritus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Description
項1.カプサイシン類及びクロタミトンを含有する皮膚外用剤であって、低級アルコールを0以上5重量%未満含有する皮膚外用剤。
項2.低級アルコール含有量が0〜3重量%である項1に記載の皮膚外用剤。
項3.低級アルコール含有量が0以上1重量%未満である項1又は2に記載の皮膚外用剤。
項4.カプサイシン類を0.005〜0.1重量%含有し、クロタミトンを3〜20重量%含有する項1〜3のいずれかに記載の皮膚外用剤。
項5.さらに水を含有する項1〜4のいずれかに記載の皮膚外用剤。
項6.さらにリン脂質及び常温液状の油分からなる群から選択される少なくとも1種を含有する項1〜5のいずれかに記載の皮膚外用剤。
項7.軟膏剤である項1〜6のいずれかに記載の皮膚外用剤。
項8.掻痒感改善用である項1〜7のいずれかに記載の皮膚外用剤。
項9.知覚過敏型肌の掻痒感改善用である項1〜8のいずれかに記載の皮膚外用剤。
表1に示す成分を含有する軟膏剤を製造した。すなわち、水にプロピレングリコールとカルボキシビニルポリマーを添加して水相とし、残りの成分を混合して油相とした後、各々を80〜90℃に加熱して混合し、密閉条件下で撹拌混合できる真空乳化機で撹拌混合し乳化することにより軟膏剤を調製した。
実施例1と同様にして表1に示す成分を含有する軟膏剤を製造した。なお、ジフェンヒドラミン及び酢酸トコフェロールは油相に添加した。
表2及び3に示す成分を使用し、実施例1と同様にして軟膏剤を製造した。なお、ジフェンヒドラミン、酢酸トコフェロール、l−メントールは油相に、エタノールは乳化後の製剤に、グリセリン及びd−ソルビトールは水相に添加した。
実施例1〜8及び比較例1〜14の軟膏剤を使用して皮膚の温熱感に関する官能試験を行った。皮膚が乾燥肌でない健常な状態(知覚過敏型肌)の者を被験者(5名)とし、被験者の首筋に実施例及び比較例の製剤を塗布してもらい、塗布直後、塗布から3、5及び10分後の温熱感を、SD法などで用いられる意味尺度を利用して6段階(最低0点、最高5点)(温熱感を覚えるほど高評点)で評価をしてもらった。評価項目及び評価方法は次のとおりである。結果を表1〜3に示した。
温熱感
評価方法
被験者5名のつけた6段階評価の点の合計点を次の区分で表した。
○:10〜12点
△:3〜9点
×:0〜2点
実施例1〜3及び比較例1〜4の軟膏剤を使用して皮膚の掻痒感の改善に関する官能試験を行った。皮膚が乾燥肌でない健常な状態(知覚過敏型肌)の者を被験者(3名)とし、被験者がかゆみを発生した時にかゆみの発生した部位に実施例及び比較例の製剤を塗布してもらい、塗布直後と塗布から5分後のかゆみの抑制作用を、SD法などで用いられる意味尺度を利用して5段階(最低1点、最高5点)で評価をしてもらった。評価項目及び評価方法は次のとおりである。結果を表4に示した。
掻痒感の改善効果
評価方法
被験者3名のつけた5段階評価の点の合計点を次の区分で表した。
○:11〜13点
△:6〜10点
×:3〜5点
表5に記載の組成にしたがって、常法により軟膏剤、乳剤、液剤、エアゾール剤、ゲル剤に製した。
Claims (7)
- カプサイシン類及びクロタミトンを含有する知覚過敏型肌の掻痒感改善用の皮膚外用剤であって、低級アルコールを0以上5重量%未満含有する皮膚外用剤。
- 低級アルコール含有量が0〜3重量%である請求項1に記載の皮膚外用剤。
- 低級アルコール含有量が0以上1重量%未満である請求項1又は2に記載の皮膚外用剤。
- カプサイシン類を0.005〜0.1重量%含有し、クロタミトンを3〜20重量%含有する請求項1〜3のいずれかに記載の皮膚外用剤。
- さらに水を含有する請求項1〜4のいずれかに記載の皮膚外用剤。
- さらにリン脂質及び常温液状の油分からなる群から選択される少なくとも1種を含有する請求項1〜5のいずれかに記載の皮膚外用剤。
- 軟膏剤である請求項1〜6のいずれかに記載の皮膚外用剤。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006097154A JP5132071B2 (ja) | 2006-03-31 | 2006-03-31 | 皮膚外用剤 |
PCT/JP2007/057245 WO2007114380A1 (ja) | 2006-03-31 | 2007-03-30 | 皮膚外用剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006097154A JP5132071B2 (ja) | 2006-03-31 | 2006-03-31 | 皮膚外用剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007269693A JP2007269693A (ja) | 2007-10-18 |
JP5132071B2 true JP5132071B2 (ja) | 2013-01-30 |
Family
ID=38563647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006097154A Active JP5132071B2 (ja) | 2006-03-31 | 2006-03-31 | 皮膚外用剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5132071B2 (ja) |
WO (1) | WO2007114380A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6668240B2 (ja) * | 2013-08-21 | 2020-03-18 | ヴェリカ ファーマシューティカルズ, インコーポレイテッドVerrica Pharmaceuticals, Inc. | 皮膚障害の処置のための組成物、方法、およびシステム |
MX2017008097A (es) | 2014-12-17 | 2018-01-09 | Verrica Pharmaceuticals Inc | Sintesis comercialmente viable de cantaridina y derivados bioactivos de cantaridina. |
JP6898241B2 (ja) | 2015-01-20 | 2021-07-07 | ヴェリカ ファーマシューティカルズ, インコーポレイテッドVerrica Pharmaceuticals, Inc. | 医薬品グレードカンタリジンの定量および調製 |
MX2019014667A (es) | 2017-06-06 | 2020-02-07 | Verrica Pharmaceuticals Inc | Tratamiento de trastornos cutaneos. |
USD900312S1 (en) | 2017-06-15 | 2020-10-27 | Verrica Pharmaceuticals, Inc. | Applicator |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1045569A (ja) * | 1996-04-26 | 1998-02-17 | Sekisui Chem Co Ltd | 貼付剤 |
JP3211027B2 (ja) * | 1998-11-13 | 2001-09-25 | 丸石製薬株式会社 | カプサイシン含有外用剤 |
WO2001010435A1 (fr) * | 1999-08-05 | 2001-02-15 | Taisho Pharmaceutical Co., Ltd. | Timbre |
JP2001213772A (ja) * | 2000-01-28 | 2001-08-07 | Health Science Center:Kk | 皮膚塗布剤組成物 |
JP2003095985A (ja) * | 2001-09-26 | 2003-04-03 | Lion Corp | 血行促進組成物 |
JP2004026721A (ja) * | 2002-06-26 | 2004-01-29 | Lion Corp | 温感外用剤組成物 |
-
2006
- 2006-03-31 JP JP2006097154A patent/JP5132071B2/ja active Active
-
2007
- 2007-03-30 WO PCT/JP2007/057245 patent/WO2007114380A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2007269693A (ja) | 2007-10-18 |
WO2007114380A1 (ja) | 2007-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2532906T3 (es) | Espuma cosmética y farmacéutica | |
US20030170194A1 (en) | Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid | |
JP2009184951A (ja) | 皮膚外用剤組成物 | |
WO2012011566A1 (ja) | タクロリムスを含有する水中油型クリーム状組成物 | |
WO2020028694A1 (en) | Liposomal compositions and methods of use | |
TWI794222B (zh) | 組成物在製備治療睡眠障礙的藥劑的用途 | |
JP5132071B2 (ja) | 皮膚外用剤 | |
EP1069886B1 (en) | Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance | |
JP2007001950A (ja) | セラミド含有皮膚外用剤 | |
JP5170973B2 (ja) | 皮膚外用剤 | |
JP6753312B2 (ja) | 医療用皮膚外用剤 | |
JP2006273789A (ja) | セラミダーゼ阻害剤、及びその阻害剤を含む皮膚外用剤、化粧料、医薬部外品 | |
WO2006057166A1 (ja) | 皮膚化粧料 | |
JPH09157172A (ja) | 皮膚外用剤及び湿疹薬 | |
US20050063930A1 (en) | Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance | |
JPH09110680A (ja) | 皮膚炎治療貼付剤 | |
JP2008115109A (ja) | 抗炎症成分を含有する皮膚外用剤 | |
MX2011001369A (es) | Composiciones para el tratamiento de la rosacea que comprenden quitosan y un acido dicarboxilico. | |
JP5513705B2 (ja) | 知覚過敏型肌掻痒感改善剤 | |
JP5063072B2 (ja) | 皮膚外用組成物 | |
JP3441387B2 (ja) | 保湿剤及び皮膚化粧料並びに入浴剤 | |
JP2016188187A (ja) | 外用医薬組成物 | |
JP7253328B2 (ja) | 外用医薬組成物 | |
JP2021195323A (ja) | 外用組成物 | |
JP3658114B2 (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090226 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120316 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120403 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120629 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120815 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121016 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121106 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151116 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5132071 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |